Transformative Biotech Names Mark Kelleher, PhD as Executive VP of R&D [Yahoo! Finance]
Thermo Fisher Scientific Inc (TMO)
Last thermo fisher scientific inc earnings: 4/22 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
ir.thermofisher.com/investors/investor-overview/default.aspx
Company Research
Source: Yahoo! Finance
Feb. 26, 2026 /PRNewswire/ -- Transformative Biotech has appointed Mark Kelleher, PhD, as Executive Vice President of Research & Development, strengthening the leadership team as it advances its extraction-free PCR platform for infectious disease testing across clinical and point-of-care settings. Transformative Biotech logo (PRNewsfoto/Transformative Biotech, LLC) Dr. Kelleher brings extensive experience in molecular diagnostics and product development, spanning both high-growth startups and globally recognized innovators. His background includes key scientific and leadership roles at 23andMe, Affymetrix, and Discovery Life Sciences, where he contributed to the development, regulatory approval, and commercialization of complex assay portfolios and integrated platforms, as well as R&D leadership roles with several emerging diagnostics companies. "Our mission is to fundamentally simplify how molecular tests are delivered and accessed," said Kevin Kraus, CEO of Transformative Biot
Show less
Read more
Impact Snapshot
Event Time:
TMO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TMO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TMO alerts
High impacting Thermo Fisher Scientific Inc news events
Weekly update
A roundup of the hottest topics
TMO
News
- Thermo Fisher Scientific Introduces New Laboratory Developed Test to Help Transplant Patients Receive the Right Dose of Critical Anti-Rejection Medication Sooner [Yahoo! Finance]Yahoo! Finance
- Why Analysts Are Closely Watching Thermo Fisher Scientific Inc. (TMO) [Yahoo! Finance]Yahoo! Finance
- Thermo Fisher Scientific Increases Quarterly DividendBusiness Wire
- How Is Thermo Fisher Scientific's Stock Performance Compared to Other Medical Devices Stocks? [Yahoo! Finance]Yahoo! Finance
- Thermo Fisher Datavant Deal Deepens Real World Data Role In Trials [Yahoo! Finance]Yahoo! Finance
TMO
Earnings
- 1/29/26 - Beat
TMO
Sec Filings
- 2/26/26 - Form 10-K
- 2/12/26 - Form 8-K
- 2/11/26 - Form 4
- TMO's page on the SEC website